THG is trading at £35.04, a -5.34% change, with no clear company-specific announcement identified to explain the October 20 decline. - THG’s October 15 update raised 2026 adjusted EBITDA guidance to £103 million; coverage linked the increase to stronger Nutrition demand and lower whey costs, not the current decline. - Broader US consumer-discretionary gains do not explain the fall; a sector cause remains unconfirmed.